President Trump Announces Initiatives for IVF and Fertility Care

On October 16, 2025, President Donald J. Trump announced a series of initiatives aimed at reducing costs and improving access to in vitro fertilization (IVF) and fertility care. The announcement included an agreement with pharmaceutical company EMD Serono to provide fertility medications at significantly reduced prices, including a discount of up to 2,320% for low- and middle-income women. This initiative is expected to save women as much as $2,200 per cycle on fertility drugs, which constitute a substantial portion of the overall costs associated with IVF treatments.

In addition to cost reductions, the administration aims to streamline the approval process for new fertility drugs by including a lower-cost alternative in the FDA’s priority review program, potentially expediting access to affordable options for patients. Furthermore, a new benefit option will allow employers to offer standalone fertility benefits, similar to dental or vision insurance, which could expand coverage for IVF and related services. This move comes in response to a landscape where many employers do not provide fertility coverage, with only 42% offering any fertility services and even fewer covering IVF specifically.

The overarching goal of these measures is to promote family growth in the United States, addressing the financial barriers that many couples face when seeking fertility treatments. The White House highlights the importance of supporting families, particularly at a time when U.S. fertility rates are declining. By making IVF and fertility care more accessible and affordable, the administration hopes to encourage more families to have children and contribute to overall family stability.

Original: article